Betulinic Acid

ID: betulinic_acid

Aliases: betula-derived triterpenoid

Type: compound

Route/form: oral or route depends on studied product

Status: research

Evidence level: mechanistic

Best data tier: mechanistic/chemistry

Support scope: non-human/mechanistic, review/regulatory

Source types: preclinical, review

Linked sources: 3

Broad outcomes: Hormones / fertility / sexual health, Longevity / mitochondrial / redox

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

Optimization domains

Research basis

Limits, risks, and missing evidence

Risk flags

Linked papers, labels, and reviews

  1. Betulinic acid ameliorates cavernous nerve injury-induced erectile dysfunction through Nrf2/HO-1 pathway activation
    preclinical / pubmed_betulinic_ed_nrf2_2026
    Direct rat cavernous-nerve-injury erectile-dysfunction paper; supports the specific Nrf2/HO-1 and mitochondrial-apoptosis claim but is not human ED evidence.
  2. Medicinal plants of the genus Betula: traditional uses and phytochemical-pharmacological review
    review / pmc_betula_betulinic_review_2015
    Broad betulin/betulinic acid pharmacology; not a compound-specific erectile dysfunction source.
  3. Anti-Inflammatory Activities of Betulinic Acid: A Review
    review / frontiers_betulinic_antiinflammatory_review_2022
    Broader betulinic-acid anti-inflammatory mechanism review; useful context, not direct erectile-function evidence.